Combination of human tumor necrosis factor-alpha (hTNF-α) gene delivery with gemcitabine is effective in models of pancreatic cancer

Cancer Statistics, 2007

Ahmedin Jemal, Rebecca L. Siegel, Elizabeth Ward et al. · CA A Cancer Journal for Clinicians · 2007 · 7.5K citations · Full text

American Cancer Society, Cancer Statistics, Epidemiology +13

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.

Howard A. Burris, Malcolm J. Moore, John Sahl Andersen et al. · Journal of Clinical Oncology · 1997 · 5.8K citations

A phase I clinical, plasma, and cellular pharmacology study of gemcitabine.

James L. Abbruzzese, Ralf Grunewald, Elizabeth A. Weeks et al. · Journal of Clinical Oncology · 1991 · 757 citations

Molecular Pharmacology, Oncology, Pharmacology +12

Treatment of Locally Unresectable Carcinoma of the Pancreas: Comparison of Combined-Modality Therapy (Chemotheraphy Plus Radiotherapy) to Chemotheraphy Alone1

JNCI Journal of the National Cancer Institute · 1988 · 577 citations

Surgical Oncology, Gastroenterology, Surgery +20

Spatial and temporal control of gene therapy using ionizing radiation

Dennis E. Hallahan, Helena J. Mauceri, Lisa P. Seung et al. · Nature Medicine · 1995 · 314 citations

Radiation Medicine, Radiobiology, Radiation Therapy +9